Dr Reddys Laboratories Share Price Today - Live Blog for June 25, 2025

Dr Reddys Laboratories Ltd witnessed a -0.35% decrease in its share price, and it is currently trading at ₹1,337.10. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price rallied by 0.03%, reaching the current market price of ₹1,341.35. This surge is indicative of the stock's recent positive performance.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,340.30. The stock is currently trading at a PE of 19.4500, while the industry PE is 34.0682, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd observed a -0.08% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,339.15. The stock has a PE ratio of 19.4500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a -0.06% decrease in its share price, and it is currently trading at ₹1,340.25. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd stock price decreased by -0.05%, with the current market value at ₹1,341.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.03% in its share price, and it currently trades at ₹1,341.65 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares experienced a 0.08% uptick, and they are currently valued at ₹1,342.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.10%, with its current market value per share resting at ₹1,340.70. This development highlights the stock's appeal to investors.

With a remarkable 0.13% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,340.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 19.4500, while the industry's PE ratio is 34.0682.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.02% uptick in its share price. As a result, it's now actively trading at ₹1,338.30 per share, making it an attractive option for investors.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,337.60. The stock is currently trading at a PE of 19.4500, while the industry PE is 34.0682, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd shares saw a -0.05% decrease, reaching a current market price of ₹1,337.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.4500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.05% in its share price, and it currently trades at ₹1,337.90 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.05% gain, with the share price now at ₹1,338.55. Notably, the stock's PE ratio stands at 19.4500, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd's shares experienced a 0.05% uptick, and they are currently valued at ₹1,338.55, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Demonstrating a commendable 0.05% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,338.55. In terms of valuation, the stock maintains a PE ratio of 19.4500, while the industry PE ratio stands at 34.0682.

The stock of Dr Reddys Laboratories Ltd is facing a -0.11% decline and is currently trading at ₹1,338.55 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.03% uptick in its share price. As a result, it's now actively trading at ₹1,340.70 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd shares experienced a -0.13% reduction, with the current market price at ₹1,339.60. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.21% recently. As of now, this stock is actively trading at a current market price of ₹1,342.30 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd share price surged by 0.03%. With its current market price standing at ₹1,341.15 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.05% upswing, and it's currently trading at ₹1,340.70 per share. Investors are closely watching this development.

After a notable 0.01% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,340.60. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.09% recently. As of now, this stock is actively trading at a current market price of ₹1,340.45 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.07% uptick in its share price. As a result, it's now actively trading at ₹1,339.50 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's shares experienced a 1.83% uptick, and they are currently valued at ₹1,339.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 1.83% recently. As of now, this stock is actively trading at a current market price of ₹1,339.00 per share, attracting attention from investors.